Cytokines: The kidney as a model for their role in tissue injury and repair

Australian and New Zealand Journal of Medicine

Volumn 26, Issue 5, 1996, Pages 636-639

  Isbel, N M ^a   Atkins, R C ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

CELL PROLIFERATION; DRUG ACTIVITY; GLOMERULONEPHRITIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY FAILURE; REVIEW; TISSUE INJURY; TISSUE REPAIR;

EID: 0029953496     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1996.tb02932.x     Document Type: Review

References (25)

1. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993; 328: 106-13.
2. Arend WP, Joslin FG, Thompson RC, Hannum CH. An IL 1 inhibitor from human monocytes: Production and characterization of biological properties. J Immunol 1989; 143: 1851-8.
3. Granowitz EV, Santos AA, Poutsiaka DD, Cannon JG, Wilmore DW, Wolff SM, Dinarello CA. Production of IL 1 RA during experimental endotoxaemia. Lancet 1991; 338: 1423-4.
4. Atkins RC. Interleukin-1 in crescentic glomerulonephritis. Kidney Int 1995; 48: 576-86.
5. Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 1995; 57: 297-309.
6. Lawrence DA. Transforming growth factor : An overview. Kidney Int 1995; 47 S49: 19-23.
7. Dower SK, McMahan C, Flack J et al. Molecular characterisation of two types of interleukin 1 receptor coding peptides on murine and human cells. J Leuk Biol (Suppl) 1990; 1: 103.
8. Jaattela M. Biologic activities and mechanisms of action of tumour necrosis factor -o/cachectin. Lab Invest 1991; 64: 724-42.
9. Stewart RJ, Marsden PA. Biologic control of the tumour necrosis factor and interleukin 1 signaling cascade. Am J Kidney Dis 1995; 25: 954-66.
10. Matsumoto K, Dowling J, Atkins RC. Production of interleukin 1 by glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J Nephrol 1988; 8: 463-70.
11. Isha N, Cashman SJ, Hay H et al. Modulation of antibody mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumour necrosis factor and IL 1. J Immunol 1989; 142: 3080-90.
12. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R. In situ production of TNFa, IL l and IL 2 R in ANCA positive glomerulonephritis. Kidney Int 1993; 43: 682-92.
13. Yoshioka K, Takemura T, Murakami K et al. In situ expression of cytokines in IgA nephritis. Kidney Int 1993; 44: 825-33.
14. Lan HY, Nikolic-Paterson DJ, Zamara M, Vannice JL, Atkins RC. Suppression of experimental crescentic glomerulonephritis by the interleukin l receptor antagonist. Kidney Int 1993; 43: 479-85.
15. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC. Interleukin 1 receptor antagonist halts progression of established crescentic glomerulonephritis in the rat. Kidney Int 1995; 47: 1303-9.
16. Johnson R, lida H, Yoshimura A, Floege J, Bowen-Pope DF. Platelet derived growth factor: A potentially important cytokine in glomerular disease. Kidney Int 1992; 41: 590-4.
17. Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 1995; 57: 297-309.
18. Noronha IL, Niemir Z, Stein H, Waldherr R. Cytokines and growth factors in renal disease. Nephrol Dial Transplant 1995; 10: 775-86.
19. Johnson RJ, Raines EW, Floege J. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet derived growth factor. J Exp Med 1992; 175: 1413-6.
20. Isaka Y, Fujiwara Y, Uueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor or platelet derived growth factor gene into the rat kidney. J Clin Invest 1993; 92:2597-601.
21. Border WA, Noble NA. Transforming growth factor in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
22. Terrell TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor - l in rats and rabbits. Int Rev Exp Pathol 1993; 34: 43-67.
23. Junaid A, Rosenberg ME, Hostetter TH. Interaction of angiotensin II and TGF in the remnant kidney. (Abstr.) J Am Soc Nephrol 1993; 4: 772.
24. Border WA, Noble NA, Ketteier M. TGF: A cytokine mediator of glomerulosclerosis and a target for therapeutic intervention. Kidney Int 1995; 47: S59-S61.
25. Border WA. Transforming growth factor and the pathogenesis of glomerular disease. Curr Op Neph Hypertension 1994; 3: 54-8.